{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Ongoing",
      "city": "Gurnee",
      "state": "IL",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "90948",
      "recalling_firm": "Akorn, Inc.",
      "address_1": "5605 Centerpoint Ct Ste A",
      "address_2": "N/A",
      "postal_code": "60031-5278",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide in the USA",
      "recall_number": "D-0147-2023",
      "product_description": "Olopatadine HCl Ophthalmic Solution, USP 0.1%, 5 mL per dropper  bottle, Rx Only, Manufactured by:  Akorn, Inc., Lake Forest, IL 60045.  NDC:  17478-105-05",
      "product_quantity": "31,073 bottles",
      "reason_for_recall": "CGMP Deviations:",
      "recall_initiation_date": "20221013",
      "center_classification_date": "20230113",
      "report_date": "20230125",
      "code_info": "Lot: Lot 1B41A, EXP 1/31/2023"
    }
  ]
}